Niclas Petri

705 total citations
9 papers, 359 citations indexed

About

Niclas Petri is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Niclas Petri has authored 9 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Niclas Petri's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Hormonal and reproductive studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Niclas Petri is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Hormonal and reproductive studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Niclas Petri collaborates with scholars based in Sweden, Denmark and United Kingdom. Niclas Petri's co-authors include Hans Lennernäs, Christer Tannergren, Lars Knutson, Patrik Forsell, Gary Williamson, Fred A. Mellon, Birgit Holst, Paul A. Kroon, Karen O’Leary and Yongping Bao and has published in prestigious journals such as Pharmaceutical Research, Transplantation and Drug Metabolism and Disposition.

In The Last Decade

Niclas Petri

9 papers receiving 350 citations

Peers

Countries citing papers authored by Niclas Petri

Since Specialization

Citations

This map shows the geographic impact of Niclas Petri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niclas Petri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niclas Petri more than expected).

Fields of papers citing papers by Niclas Petri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niclas Petri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niclas Petri. The network helps show where Niclas Petri may publish in the future.

Co-authorship network of co-authors of Niclas Petri

This figure shows the co-authorship network connecting the top 25 collaborators of Niclas Petri. A scholar is included among the top collaborators of Niclas Petri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niclas Petri. Niclas Petri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	P3.41: Pharmacokinetics and Pharmacodynamics of Glucagon-like Peptide (GLP-2) Analogue Apraglutide (FE 203799) in Adult Healthy Volunteers: Results of a Phase I Trial 2019 ·Transplantation ·Federico Bolognani, Violetta Dimitriadou, Niclas Petri, Jean Bourgouin, (unknown), R. N. Porter, Christian P. Meyer, Luca Santarelli	3
2	Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate in Healthy Adult Subjects 2018 ·Clinical Therapeutics ·(unknown), Niclas Petri, (unknown)	2
3	Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men 2017 ·Clinical Drug Investigation ·Håkan Olsson, Niclas Petri, Lars Erichsen, Anders Malmberg, Lars Grundemar	12
4	Biliary Excretion of Ximelagatran and Its Metabolites and the Influence of Erythromycin Following Intraintestinal Administration to Healthy Volunteers 2010 ·The Journal of Clinical Pharmacology ·(unknown), Ulf G. Eriksson, Lars Knutson, Kurt‐Jürgen Hoffmann, (unknown), (unknown), Niclas Petri, Hans Lennernäs	2
5	Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers 2006 ·International Journal of Clinical Pharmacology and Therapeutics ·Niclas Petri, Magnus Borga, (unknown), Mikael Hedeland, Ulf Bondesson, Hans Lennernäs	23
6	FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL 2006 ·Drug Metabolism and Disposition ·Niclas Petri, (unknown), Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson, Hans Lennernäs	32
7	Transport Characteristics of Fexofenadine in the Caco-2 Cell Model 2004 ·Pharmaceutical Research ·Niclas Petri, Christer Tannergren, (unknown), Hans Lennernäs	108
8	ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO 2003 ·Drug Metabolism and Disposition ·Niclas Petri, Christer Tannergren, Birgit Holst, Fred A. Mellon, Yongping Bao, Geoff W. Plumb, (unknown), Karen O’Leary, Paul A. Kroon, Lars Knutson, Patrik Forsell, (unknown), Hans Lennernäs, Gary Williamson	176
9	In vivo permeability studies in the GI tract. 2003 ·Niclas Petri, Hans Lennernäs	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact